Basic Betapace Information

• INN (International Nonproprietary Name): Sotalol hydrochloride.
• Brand Names Available In United States: Betapace, Betapace AF, Sorine; oral tablets and multiple generics are available.
• ATC Code: C07AA07 — C07 Beta Blocking Agents; AA Non-Selective Beta Blocking Agents; 07 Sotalol.
• Forms & Dosages: Tablets in strengths commonly available as 80 mg, 120 mg, 160 mg, 240 mg; oral liquid formulations are generally unlicensed or specially prepared for pediatric use.
• Manufacturers In United States: Key manufacturers and suppliers include Mylan, Teva, Apotex, and original Betapace supplied historically by King Pharmaceuticals / Bristol-Myers Squibb.
• Registration Status In United States: FDA approved Betapace (1992) and Betapace AF (2000); product is listed as a prescription medication in US registries.
• OTC / Rx Classification: Prescription Only (Rx) in major regions including the United States.

Everyday Use & Best Practices

Worried about when to take betapace and how it will fit into your day?

Morning Vs Evening Dosing

Sotalol is commonly prescribed twice daily, for example Betapace 80 mg BID for many starting regimens.

Space doses about 12 hours apart to keep steady blood levels and predictable heart-rate effects.

Typical adult starting regimens for ventricular arrhythmia and atrial fibrillation often begin at 80 mg twice daily with careful titration in hospital settings.

Take doses roughly at wake time and again in the evening — for example 7 AM and 7 PM — to help adherence and symptom tracking.

If you notice bradycardia, dizziness, or excessive fatigue, contact your clinician to discuss lowering dose or shifting timing.

Hospital initiation and ECG monitoring are advised during dose escalation because of dose-related proarrhythmic risk.

Taking With Or Without Meals

Sotalol tablets may be taken with or without food.

Keeping the timing relative to meals consistent helps predictable absorption and routine use.

Avoid large caffeine or alcohol intake around dosing because those can affect heart rhythm and symptoms.

• Daily Schedule Example: 7 AM dose, 7 PM dose; take each dose at roughly the same time every day.
• Medication-Time Checklist: Set two daily alarms; record pulse rates after first week; note any dizziness or breathlessness.

Safety Priorities

Who should never be started on betapace and what activities need limits when you begin therapy?

Who Should Avoid It

Do not take sotalol if you have congenital or acquired long QT syndrome.

Do not take sotalol with overt heart failure or high-grade AV block unless you have a functioning pacemaker.

A creatinine clearance below recommended thresholds — standard regimens are often contraindicated when CrCl is under 40 mL/min — means sotalol should be avoided or adjusted.

Known hypersensitivity to sotalol is an absolute exclusion.

People with asthma or COPD should use caution because sotalol is a non-selective beta blocker and may worsen bronchospasm.

Activities To Limit

Until you know how sotalol affects you, avoid driving or operating heavy machinery if you feel dizzy or lightheaded.

Limit strenuous exercise while your dose is being adjusted and until monitoring is complete.

Avoid sudden position changes that can promote dizziness during the first days of treatment.

• Contraindications Checklist: Long QT, heart failure, high-grade AV block (unless pacemaker), CrCl <40 mL/min, hypersensitivity.

Dosage & Adjustments

How will your prescriber choose a starting dose and when will adjustments be needed?

General Regimen

Typical adult starting doses for ventricular arrhythmias are often 80 mg twice daily.

For atrial fibrillation/flutter, Betapace AF usually starts at 80 mg twice daily and may be titrated up to 160 mg twice daily in a monitored setting.

Maximum reported regimens include 160 mg twice daily for selected indications under close supervision.

Initiation and titration generally occur inpatient with ECG and renal monitoring because of dose-related torsades de pointes risk.

Special Cases

Renal impairment requires either dose reduction or extending the dosing interval based on creatinine clearance; severe renal dysfunction may contraindicate standard dosing.

Elderly patients should start at lower doses due to common renal decline and higher bradycardia risk.

Pediatric dosing is specialist-managed and requires body surface area calculations with reported Class III effects observed near 210 mg/m2/day.

• Adjustment Checklist By Creatinine Clearance: CrCl ≥60 mL/min standard dosing; CrCl 40–59 mL/min consider longer interval or lower dose; CrCl <40 mL/min often contraindicated for standard regimens.

User Testimonials

What do real patients report after starting betapace?

Positive Reports

Many patients describe fewer palpitations and improved rhythm control after careful hospital titration to a stable dose.

Users who tolerated sotalol typically report reduced symptomatic atrial fibrillation episodes and better sleep due to fewer nighttime arrhythmias.

Some patients say symptom predictability reduced daily anxiety about irregular heartbeats once therapy was optimized.

Common Challenges

Common initial complaints include dizziness, fatigue, and the logistical burden of hospital admission for initiation and repeated ECGs and labs.

Some patients are concerned about QT prolongation and the need for frequent monitoring during dose changes.

Patients with asthma symptoms sometimes find intolerance because sotalol is non-selective and can cause bronchospasm.

• Real-World Pros: Better rhythm control, fewer palpitations, improved sleep.
• Real-World Cons: Dizziness, need for inpatient start, monitoring requirements, possible respiratory intolerance.

• Patient Checklist For Clinician: New dizziness, fainting, worsening breathlessness, palpitations, or any syncope — report immediately.

Buying Guide

Where can you obtain betapace and how do prices compare between brand and generic options?

Pharmacy Sources

Sotalol is prescription-only across major regions, and brand names include Betapace, Betapace AF, and Sorine along with multiple generics labeled as sotalol or sotalol hydrochloride.

Key manufacturers and suppliers include Mylan, Teva, Apotex, plus local generics in various countries.

EU labels include Sotalol Teva and Sotalex; in Romania check the ANMDMR registry for local availability.

In our online pharmacy, betapace is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

Generics are usually less expensive and widely available in the US and EU.

Cash prices, insurance formularies, and mail-order options vary; ask your pharmacist about tiered copay options and manufacturer coupons.

• Tip: Verify online pharmacy credentials and check FDA/EMA registries to avoid counterfeit supplies.

What’s Inside & How It Works

What is sotalol made of and why does it affect heart rhythm?

Ingredients Overview

The active ingredient is sotalol hydrochloride (INN).

Dosage forms include tablets in strengths commonly 80 mg, 120 mg, 160 mg, and 240 mg, with oral liquids rarely prepared for pediatric use.

Excipients vary by manufacturer; consult your pharmacist if you have dye or binder allergies.

Mechanism Basics

Sotalol is a non-selective beta blocker with Class III antiarrhythmic effects that prolong the cardiac action potential and QT interval.

Its dual action suppresses atrial and ventricular arrhythmias but increases the risk of torsades de pointes when doses are escalated or when combined with QT-prolonging cofactors.

• Allergy/Excipient Checklist: Ask about dyes, lactose, or gelatin excipients if you have known sensitivities.

Main Indications

When is betapace officially used and when might clinicians consider it off-label?

Approved Uses

FDA and EMA approvals include treatment of ventricular arrhythmias and maintenance of sinus rhythm in atrial fibrillation or flutter.

Betapace was approved in the United States in 1992 and Betapace AF in 2000 for atrial fibrillation/flutter.

Inpatient initiation and careful titration are commonly required for safety and monitoring purposes.

Off-Label Uses

Off-label prescribing occurs in select arrhythmic presentations or pediatric cases under specialist oversight with differing dosing and monitoring.

Betapace and Betapace AF are not interchangeable for ventricular versus atrial indications without prescriber guidance.

• Checklist: Confirm indication, document rationale, and verify which formulation (Betapace vs Betapace AF) is intended before dispensing.

Interaction Warnings

Which foods, electrolytes, or drugs can make sotalol riskier?

Food Interactions

No major food restrictions are specified, but consistent meal timing is helpful for predictable absorption.

Avoid heavy alcohol intake around dosing and watch electrolyte intake because hypokalemia and hypomagnesemia increase torsades risk.

Grapefruit is not listed as a major interaction with sotalol, but check with a pharmacist for combined medication risks.

Drug Conflicts

High-risk interactions include other QT-prolonging drugs such as certain antidepressants, antipsychotics, macrolide antibiotics, antiemetics, and other Class I or III antiarrhythmics.

Medications that add bradycardia risk include other beta blockers, nondihydropyridine calcium channel blockers, and digoxin.

Diuretics can lead to electrolyte disturbances that predispose to torsades and require monitoring.

• Interaction Checklist: Bring a complete medication list including OTCs and supplements to every appointment.

Latest Evidence & Insights

What do guidelines and safety data say about the biggest risks and monitoring needs?

Sotalol carries a dose-related torsades de pointes risk that is highest during initial titration.

Clinical practice commonly recommends inpatient initiation with continuous ECG monitoring for at least 72 hours during dose escalation.

Baseline and serial renal checks are essential because dosing and safety depend heavily on creatinine clearance.

Comparative choices include amiodarone, dronedarone, flecainide, and others; the optimal agent depends on comorbidities such as heart failure, lung disease, and QT history.

• Key Evidence Points: Inpatient initiation for safety; correct electrolytes first; choose alternatives based on comorbidity profile.

• Clinician One-Page Checklist: Baseline ECG, baseline K+/Mg2+, serum creatinine/CrCl, inpatient telemetry during titration, documented rationale comparing sotalol with alternatives.

Alternative Choices

What are common alternatives when sotalol is unsuitable or not tolerated?

Amiodarone is effective but carries significant long-term toxicity requiring thyroid, liver, and pulmonary surveillance.

Dronedarone (Multaq) is an alternative in certain AF patients but may be less effective in some settings.

Flecainide and propafenone are Class I agents useful for selected atrial fibrillation patients without structural heart disease.

Mexiletine is an option for certain ventricular arrhythmias in specialist hands.

• Practical Tip: Match the drug to comorbidities and the patient’s tolerance for monitoring and side effects.

Regulation Snapshot

Is betapace approved and what are the prescription requirements?

Approval Status

The FDA approved Betapace in 1992 and Betapace AF in 2000 for their respective indications.

EMA and national regulators have approved generic sotalol products across Europe with local registries listing availability.

Romania and other EU countries publish market status on national portals such as the ANMDMR database.

Prescription Requirements

Sotalol is a prescription-only medication in all major regions.

Although inpatient initiation with telemetry is standard of care for safety, this requirement is clinical rather than a legal restriction in most regions.

Insurers may require hospitalization or prior authorization for initial dosing or for certain formulations.

FAQ Section

Quick answers to the questions patients ask most about betapace.

Quick Answers

Missed Dose: Take as soon as remembered unless it is near the next scheduled dose; do not double the next dose.

Storage: Store at room temperature, typically 20–25°C, and protect from excessive heat and moisture.

Pregnancy/Lactation: Use only if clearly needed and after discussion with your provider because safety data are limited.

Driving: Do not drive if you feel dizzy, lightheaded, or excessively fatigued after starting or changing dose.

When To Call Your Doctor

Seek urgent care for fainting, severe dizziness, chest pain, or palpitations that feel worse after starting sotalol.

Call immediately if you have shortness of breath, signs of very slow pulse, or new syncope.

If an ECG shows prolonged QT or lab tests reveal low potassium or magnesium, contact your provider right away.

• FAQ Checklist For Wallet Card: Dose times, emergency symptoms, prescriber and pharmacy contact info, baseline ECG date.

Guidelines For Proper Use

What monitoring is needed and how should initiation and follow-up be organized?

Monitoring Schedule

Obtain baseline ECG, serum potassium and magnesium, and renal function including serum creatinine and estimated CrCl prior to initiation.

During initiation, continuous ECG monitoring for at least 72 hours is commonly recommended while titrating dose in hospital.

Check creatinine daily during titration if inpatient and reassess electrolytes regularly.

Long-term care includes periodic ECGs, renal checks, and symptom reviews at intervals guided by dose and comorbidities.

Hospital Initiation & Follow-Up

Initiation is often inpatient with telemetry because torsades risk is dose-related and highest during titration.

Ensure clear communication between the inpatient team, cardiology, and the outpatient provider on the follow-up plan.

Arrange follow-up labs and ECG within 1–2 weeks after discharge and sooner if symptoms occur.

• Baseline Tests Checklist: ECG, K+, Mg2+, serum creatinine/CrCl, medication review.
• Inpatient Steps: Continuous telemetry, daily ECGs or monitoring as directed, electrolyte correction before dose increases.
• Outpatient Timeline: First clinic or phone check within 3–7 days, ECG and labs at 1–2 weeks, then periodic checks.

Delivery Across United States